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Background: There is no single optimal exercise testing protocol for children and adolescents with cystic ﬁbrosis (CF) that differs widely in age
and disease status. The aim of this study was to develop a CF-speciﬁc, individualized approach to determine workload increments for a cycle
ergometry testing protocol.
Methods: A total of 409 assessments consisting of maximal exercise data, anthropometric parameters, and lung function measures from 160
children and adolescents with CF were examined. 90% of the database was analyzed with backward linear regression with peak workload (Wpeak)
as the dependent variable. Afterwards, we [1] used the remaining 10% of the database (model validation group) to validate the model's capacity to
predict Wpeak and [2] validated the protocol's ability to provide a maximal effort within a 10±2 minute time frame in 14 adolescents with CF who
were tested using this new protocol (protocol validation group).
Results:No signiﬁcant differences were seen inWpeak and predictedWpeak in the model validation group or in the protocol validation group. Eight of 14
adolescents with CF in the protocol validation group performed a maximal effort, and seven of them terminated the test within the 10±2 minute time
frame. Backward linear regression analysis resulted in the following equation: Wpeak (W)=−142.865+2.998×Age (years)−19.206×Sex (0=male;
1=female)+1.328×Height (cm)+23.362×FEV1 (L) (R=.89; R
2=.79; SEE=21). Bland–Altman analysis showed no systematic bias between the
actual and predicted Wpeak.
Conclusion: We developed a CF-speciﬁc linear regression model to predict peak workload based on standard measures of anthropometry and
FEV1, which could be used to calculate individualized workload increments for a cycle ergometry testing protocol.
© 2012 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.Keywords: Exercise capacity; Cycle ergometer protocol; Peak workload1. Introduction
The clinical utility of exercise and exercise testing in the
diagnosis and treatment as well as the primary and secondary
prevention of chronic conditions is widely recognized by
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doi:10.1016/j.jcf.2012.05.004cardiopulmonary exercise testing (CPET) is increasingly used
to evaluate exercise capacity and define training intensity in
adolescents with chronic lung diseases like cystic fibrosis (CF)
[1,2]. Numerous protocols have been used in the past to
evaluate physical fitness in adolescents with chronic condi-
tions, but there is still no consensus with regards to the best
protocol to be used in the clinical setting. Moreover, there is
some question as to whether these exercise testing protocols
should vary by pediatric condition or even between patients
with the same condition. Ultimately, the characteristics of the
patient and the purpose of the exercise test will determine
which protocol is most suited for each individual patient. Asideby Elsevier B.V. All rights reserved.
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length of the exercise test represents an additional important
criterion to consider when designing a protocol that will elicit
maximal or peak oxygen uptake and demonstrate good
reproducibility of commonly measured exercise parameters
(e.g. ventilatory threshold). While a test duration of 10±2 min
has been recommended to allow the patient to reach their limit
of tolerance [3,4]. Midgley et al. nuanced this recommendation
by suggesting that cycle ergometer tests should last between 7
and 26 min with a focus on tolerable workload increments
rather than test duration, per se [5].
Progressive incremental cycle ergometer protocols, continu-
ous incremental (ramp) protocols, and protocols with short stage
duration (e.g. 1 min) are very efficient at inducing maximal
exercise responses in an optimal time frame (~10 to 12 min). The
Godfrey protocol was the first 1-minute incremental protocol
systematically used in pediatric CF patients [6,7]. This protocol
separates subjects into 3 groups based on height with workload
increments increasing with height from 10 W to 15 W and 20 W
per min. The large differences in disease severity and the
progressive nature of CFmake a more individualized approach to
the incremental exercise test critical. It is generally accepted that,
to date, there is no single best exercise testing protocol to answer
all questions in individuals with CF with a wide range of ages
and disease states [8,9]. Therefore, we aimed to develop a CF-
specific, individualized approach from standard measures of
anthropometry and lung function in children and adolescents to
determine workload increments for a maximal cycle exercise test.
2. Methods
Maximal effort cycle ergometer CPET data (n=409) from
160 children and adolescents with CF receiving care at the
Cystic Fibrosis Center of the Wilhelmina Children's Hospital,
Utrecht, the Netherlands, were analyzed. Body weight, height,
lung function and exercise capacity were determined as part of
routine measures at the patient's annual medical check-up.
Since all measurements were a part of patient standard of care,
ethical approval and informed consent were not required
according to Dutch Law.
Out of the database, a regression model was developed out
of 90% of the data (reference group). Afterwards, we [1] used
the remaining 10% of the database (model validation group) to
validate the model's capacity to predict Wpeak and [2] validated
the protocol's (minute increment=predicted Wpeak /10) ability
to provide a maximal effort within a 10±2 minute time frame in
14 adolescents with CF who were tested using this new
protocol (protocol validation group). The CPET was part of
their usual care at the annual CF check-up.
2.1. Spirometry
Spirometry and body plethysmography were performed before
and after bronchodilation with salbutamol (800 μg), using a
pneumotach apparatus and a volume-constant plethysmograph
(Master Lab system, E. Jaeger, Würzburg, Germany). Lung
function measurements included total lung capacity (TLC),residual volume (RV), and forced expiratory volume in 1 s
(FEV1). These results were compared with predicted values for
healthy subjects matched for age, height, and gender [10].2.2. Cardiopulmonary exercise test (CPET)
After bronchodilation with salbutamol, all participants per-
formed a progressive cardiopulmonary exercise test (CPET)
on an electronically braked cycle ergometer (Jaeger physis;
Carefusion, Houten, The Netherlands) to assess exercise ca-
pacity. Ergometer seat height was adjusted to the participant's
comfort and leg length. Participants rested until all measured
variables were stable, and then began cycling at a workload of
0 W; the workload was increased 15 W/min until the partici-
pant stopped due to volitional exhaustion. Throughout the
exercise, participants breathed through a mask (Hans Rudolph
Inc., Kansas City, MO) that was connected to a calibrated
metabolic cart (Oxycon Pro, Carefusion, Houten, The
Netherlands). Expired gas was passed through a flow meter,
oxygen analyzer, and carbon dioxide analyzer, which were
connected to a computer that calculated breath-by-breath
minute ventilation (VE), oxygen uptake (VO2), carbon dioxide
production (VCO2) and respiratory exchange ratio (RER) from
conventional equations. Heart rate was monitored continuously
by 3-lead electrocardiography (Hewlett-Packard, Amstelveen,
Netherlands). The oxygen uptake and workload completed in the
final 30 s prior to exhaustion were considered to be VO2peak and
Wpeak, respectively. Relative peak oxygen uptake (VO2peak/kg)
was calculated by dividing VO2peak by total body mass. All
participants included in the analysis were required to have
performed a maximal effort test, which was defined by a
combination of subjective and objective criteria. Subjective
criteria included subject exhaustion (unsteady biking, sweating,
facial flushing) or an inability to maintain the required cadence
of 60 rpm despite strong verbal encouragement. Objective
criteria included: (1) peak heart rate (HRpeak)N180 bpm [11]
and (2) respiratory exchange ratio (RER)N1.00. Based on
previous literature, a true maximal effort required participants to
demonstrate both objective and subjective criteria [12].2.3. Statistics
All variables were tested for normality with the Kolmogorov–
Smirnov test. Backward linear regression analysis was performed
using the data of the reference group. Peak workload (Wpeak) was
defined as the dependent variable in the model, while gender,
height, and FEV1 (L) were selected as independent variables. The
model validation group was used to validate the models capacity
to predict Wpeak. Student's t-tests or Mann–Whitney test was
used to assess differences between the reference and validation
groups for gender distribution, height, weight, FEV1%pred, Wpeak
and VO2peak. For the model validation group, a Bland–Altman
plot was used to assess any systematic bias between actual Wpeak
and Wpeak predicted. After developing the regression equation,
we validated the new protocol in the protocol validation group.
Table 2
Correlation coefficients for weight, age and lung function with Wpeak in males
and females.
Wpeak
Pearson correlation Age .64
Sex − .42
Weight .78
FEV1pp .32
Height .80
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analyses were performed in SPSS 15.0 for Windows (Chicago,
IL, USA).
3. Results
Kolmogorov–Smirnov tests revealed that FEV1 (L), Wpeak,
HRpeak, RERpeak and time to exhaustion (Tlim) were not normally
distributed. However, the residuals of the model predicting Wpeak
were normally distributed. No complications were observed
during or after exercise testing.
RERpeak of the total group was 1.19±0.09 [range 1.0–1.67]
and HRpeak 190±7 [range 180–210] beats per minute (bpm). No
differences in maximal exercise parameters were found between
both groups (reference group RERpeak 1.20±0.09 [range 1.0–
1.67] and HRpeak 189±7 [range 180–210 bpm] versus model
validation groupRERpeak 1.18±0.09 [range 1.0–1.45] andHRpeak
190±6 [range 180–210 bpm]; p=.33 for RERpeak and HRpeak).
Anthropometric characteristics of both groups are presented in
Table 1. Mean FEV1%pred for the validation and reference groups
was 86.9±19.3% and 87.2±17.4% (p=.91), respectively. Gender
distribution between the reference and validation group was
similar (38%♀ and 62%♂ in the reference group vs. 45%♀ and
55%♂ in the validation group; X2 test p=.503). No differences
in age were seen between the validation and regression group
(14.2±1.9 [11–18] vs. 14.5±2.0 [8–18] years; p=.41).
For the reference group, mean Wpeak was 171.2±46.3 W
with a mean Tlim of 11.4 min [range 5.0–20.0 min]. For the
model validation group, mean Wpeak was 164.6±38.6 W, and
mean Tlim was 11.0 min [range 7.0–16.0 min]. No differences
were noted for Wpeak (p= .496) or Tlim (p= .496) between the
reference and model validation groups.
Height, weight, FEV1 (L and %predicted), gender, and age
were all significantly associated with Wpeak (.319–.803;
pb .001) in pediatric patients with CF, with the strongest
correlation found for FEV1 (L) (r .803; pb .001) (see Table 2).
Inclusion of these variables in backward linear regression
analysis resulted in the following equation:
Wpeak Wð Þ ¼ −142:865þ 2:998 Age yearsð Þ−19:206
Sex 0 ¼ male; 1 ¼ f emaleð Þ þ 1:328
Height cmð Þ þ 23:362 FEV1 L:min−1
 
R ¼ :89; R2 ¼ :79; SEE ¼ 21:0:
Extrapolating this equation to the model validation group
resulted in a predicted mean Wpeak of 164.6±38.6 W, compared
with the actual mean Wpeak of 166.5±38.1 (p= .09).Table 1
Anthropometric values.
Age Gender Weight Height FEV1pred
Reference
group
14.5±2.0 17♀ 21♂ 50.0±12.2 162.6±12.0 87.2±17.4
Validation
group
14.2±1.9 140♀
231♂
49.1±9.9 161.9±11.1 86.9±19.3Bland–Altman analysis showed no systematic bias between
the actual and predicted Wpeak (see Fig. 1).
Based on these findings, we conclude that the model
developed in the present study to predict Wpeak from standard
anthropometric variables is valid. Ultimately, this approach will
provide more optimal CF-specific exercise testing of compara-
ble test duration across a wide variety of ages and disease
states.
We validated the developed protocol (increments per minute=
predicted Wpeak /10) in 14 adolescents with CF. Six of them were
excluded from further analysis while they did not meet the above
mentioned criteria for maximal effort. The remaining eight
participants (3 female, 5 male; age 15.6±2.2 years [12–19];
FEV1 3.0±0.8 L; FEV1%pred 87±19%; height 167±10 cm; weight
52±9 kg) were used to validate the protocol (Tlim 10.8±1.4 min
[9.2–13.3 min]; RERpeak 1.28±0.06 [range 1.21–1.40] andHRpeak
185±4 [range 181–189 bpm]). Seven of them performed a
maximal effort within the targeted 10±2 minute time frame.
When we compare the Tlim of the CF-specific protocol
with the estimated Tlim of the Godfrey protocol (Wpeak /20 W
per min), much more variance in Tlim would have been found
in the Godfrey protocol (95% CI for CF specific protocol 9.7–
12.0 min versus 7.8–12.0 min) (see Fig. 2).
We found no difference betweenmeasuredWpeak and estimated
Wpeak (197±50 W versus 186±38 W; p=.22). Bland–AltmanFig. 1. Bland–Altman plot of the measured Wpeak and predicted Wpeak in the
model validation group showing the bias and limits of agreement. Bland–
Altman plot has been developed from the 10% validation group.
Fig. 2. Vertical point plot of the mean Tlim (95% CI) of both protocols.
553H.J. Hulzebos et al. / Journal of Cystic Fibrosis 11 (2012) 550–554analysis showed no systemic bias between actual and predicted
Wpeak (mean difference 10.9 W; LOA+55.7; −33.9 W) (see
Fig. 3).
4. Discussion
We aimed to develop a CF-specific linear regressionmodel for
children and adolescents to predict peak workload based on
standard measures of anthropometry and FEV1, which could then
be used to calculate individualized workload increments for an
exercise protocol wherein participants achieve cardiopulmonary
exhaustion in approximately 10 min. While an individualized
exercise protocol has previously been shown to be feasible in
children and adolescents with various diseases, it is important to
note that in that study the individualization was based on peak
oxygen uptake rather than peak workload [13]. In the current
study, height, weight, FEV1, gender and age were significantly
associated with Wpeak in adolescent patients with CF. Given the
strength of the relationship between Wpeak and height, it seems
that the exercise protocol developed by Godfrey, who basedFig. 3. Bland–Altman plot of the measured Wpeak and predicted Wpeak in the
protocol validation group.the increments on the individual's height (10 W/minb120 cm;
15 W/min 120–150 cm; 20 W/minN150 cm), already provides
better individualization of the exercise increments for children
and adolescents (with CF) than standard increments.
Generally, a workload increment that brings the subject to
their limit of tolerance in about 10 min is suggested to provide
optimal cardiopulmonary assessment [4]. Despite the grading of
the workload increments according to size in the Godfrey
protocol, the smallest healthy children and adolescents complete
the test in about 4 min, whereas tests for the largest healthy
children last roughly 10 min [7]. The preliminary termination
seen in small children and adolescents may be due to workload
increments that are too large, resulting in premature exhaustion of
the muscles of the lower limbs before the attainment of cardiac or
respiratory limits [13]. Additionally, VO2 on-kinetics are
reportedly slowed in steeper ramp slopes, [14] which may
compromise the aerobic contribution to total energy delivery [14]
and lead to premature exhaustion of the anaerobic energy system
in the local muscles. Therefore, at least in smaller children and
adolescents, as is the case in CF, a protocol based solely on a
single variable such as height does not seem to provide the
appropriate workload increments to achieve VO2peak in the
suggested 10-minute time frame.
Conversely, a multivariable-based exercise protocol may
allow for better selection of workload increments leading to
more optimal exercise duration. Linear regression analysis
showed gender, FEV1, age and height to be significant and
independent predictors of Wpeak. The resulting model explained
79% of the variance in Wpeak. Validation of the models' capacity
to predict Wpeak showed no significant difference between the
measured Wpeak and estimated Wpeak in a sample of children and
adolescents with CF. Moreover, Bland–Altman analysis showed
no systematic bias between the measured Wpeak and estimated
Wpeak. Additionally, we validated the new incremental protocol
and found no difference between measured Wpeak and estimated
Wpeak (197±50 W versus 186±38 W; p=.22), whereas the
maximal effort was performed within the targeted 10±2 minute
time frame in seven of the eight participants who performed a
maximal effort.
To ensure a maximal effort, we used previously used modified
criteria in our laboratory [12]. The achievement of these criteria
was of critical importance as questions about cardiopulmonary
limiting factors or cardiopulmonary exercise capacity can only be
answered when the cardiopulmonary system has truly reached its
limitations. Individualization of the exercise protocol has been
shown to provide achievement of the maximal exercise criteria in
approximately 10 minute exercise duration in a higher proportion
of children and adolescents [13].
Based on these findings, we conclude that the model
developed in the present study to predict Wpeak from standard
anthropometric variables is valid. Dividing the predicted Wpeak
by 10 to determine individualized workload increments for the
maximal exercise test will allow participants to achieve true
cardiopulmonary exhaustion in the recommended 10-minute
time frame. Ultimately, this approach will provide more
optimal CF-specific exercise testing of comparable test duration
across a wide variety of ages and disease states. However, the
554 H.J. Hulzebos et al. / Journal of Cystic Fibrosis 11 (2012) 550–554equation has not been tested or validated in adult patients with
CF. Further research to cross-validate this individualized
protocol in adolescents and adults with CF is suggested.
Additionally, CF-specific normative data for Wpeak are required
for the interpretation of the test results.
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